From: Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line
Surviving Fraction | |||
---|---|---|---|
DOX Concentration (μg/ml) | DOX | DOX+RSVL Simultaneously | DOX+RSVLRSVL 24h before |
0.0625 | 0.97 ± 0.17 | 0.10a ± 0.013 | 0.173a ± 0.03 |
0.25 | 0.92 ± 0.112 | 0.091a ± 0.018 | 0.124a ± 0.006 |
0.5 | 0.29 ± 0.061 | 0.089a ± 0.034 | 0.047a,b± 0.003 |